Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars ...

Pharma stocks rise as Cipla faces supply issues, Zydus gains FDA approval, and Biocon secures funding through a QIP.

Biocon Limited ( ($IN:BIOCON) ) has issued an update. Biocon Limited has significantly increased its stake in its unlisted material subsidiary, ...

Stocks to Watch today, January 7, 2026: Indian equities are expected to open lower on Wednesday, tracking mixed global cues.

Biotech firm Biocon on Thursday said it has raised ₹4,150 crore through a Qualified Institutions Placement (QIP) process. The initiative saw issuance of 1,12,664,585 equity shares of face value ₹5 ...

Biocon said the proceeds would be primarily used to meet the cash consideration payable to Mylan Inc, now Viatris, for the ...

Sical Logistics Ltd., KP Energy Ltd., Mazagon Dock Shipbuilders Ltd., Biocon Ltd. and ICICI Lombard General Insurance Co. are ...

Stocks including TCS, Adani Energy Solutions, Anand Rathi Wealth, HCL Technologies, Biocon, NBCC, NLC India, KRBL and more ...

Track top stocks like TCS, HCL Tech, Biocon, and Maruti Suzuki after fresh earnings and deals—get the latest market movers ...

In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg ...

The board of Biocon has approved the issue of 11.26 crore equity shares of face value of ₹5 each to eligible institutions.

On Tuesday, January 6, the Sensex and Nifty 50 extended their losing streak for a second straight session as profit-booking ...